FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005698822> ?p ?o ?g. }

• W2005698822 endingPage "1727" @default.
• W2005698822 startingPage "1711" @default.
• W2005698822 abstract "The introduction of combination products, for the coadministration of an inhaled corticosteroid (ICS) with a long-acting beta2-agonist in a single inhaler, has greatly simplified asthma therapy. The two combination inhalers currently available, Symbicort (budesonide/formoterol in a single inhaler) and Seretide (salmeterol/fluticasone), comply with Step 3 of international guidelines that recommend the addition of a long-acting beta2-agonist to ICS in patients who are inadequately controlled on ICS alone. Importantly, combination inhalers ensure that patients cannot neglect their ICS maintenance therapy in favour of the long-acting beta2-agonist--which may improve adherence and overall asthma control. In vitro experiments suggest that ICS and long-acting beta2-agonists may interact beneficially when they are administered via one inhaler. The efficacy and tolerability of budesonide/formoterol and salmeterol/fluticasone have been demonstrated. There are currently two approaches for treating asthma using combination therapy--fixed and adjustable dosing. Fixed dosing with budesonide/formoterol or salmeterol/fluticasone provides effective asthma control in line with guideline goals. However, given the inherent variability of asthma, there is increasing evidence that adjusting the dose of ICS according to fluctuations in symptoms is beneficial. Findings from a series of studies comparing fixed and adjustable symptom-guided dosing regimens demonstrate that adjustable dosing may improve asthma control at an overall lower steroid dose. Ultimately, if adjustable dosing proves to be an effective treatment option, it may be possible to use budesonide/formoterol for both maintenance therapy and symptom relief, thereby overcoming the need for a separate reliever inhaler. This is because formoterol has a more rapid onset and greater dose-related effects than salmeterol in salmeterol/fluticasone. Given that all patients are different, with different disease severities and treatment preferences, both fixed and adjustable dosing strategies are likely to be important in the long-term management of asthma. It is possible that different treatment options will be used for different patients, depending on their disease severity, personality and ability to adhere to therapy." @default.
• W2005698822 created "2016-06-24" @default.
• W2005698822 creator A5001571542 @default.
• W2005698822 date "2004-09-22" @default.
• W2005698822 modified "2023-09-25" @default.
• W2005698822 title "Combination therapy in asthma -fixed or variable dosing in different patients?" @default.
• W2005698822 cites W125359851 @default.
• W2005698822 cites W1902445705 @default.
• W2005698822 cites W1976392240 @default.
• W2005698822 cites W1977761895 @default.
• W2005698822 cites W1978213231 @default.
• W2005698822 cites W1987062528 @default.
• W2005698822 cites W1987343787 @default.
• W2005698822 cites W1989813987 @default.
• W2005698822 cites W1995257163 @default.
• W2005698822 cites W1995797675 @default.
• W2005698822 cites W1996275057 @default.
• W2005698822 cites W2006499560 @default.
• W2005698822 cites W2008053364 @default.
• W2005698822 cites W2013334397 @default.
• W2005698822 cites W2027285152 @default.
• W2005698822 cites W2027817387 @default.
• W2005698822 cites W2043671273 @default.
• W2005698822 cites W2047728537 @default.
• W2005698822 cites W2049638018 @default.
• W2005698822 cites W2052344581 @default.
• W2005698822 cites W2079029414 @default.
• W2005698822 cites W2080649045 @default.
• W2005698822 cites W2082466693 @default.
• W2005698822 cites W2087474459 @default.
• W2005698822 cites W2098188679 @default.
• W2005698822 cites W2098633046 @default.
• W2005698822 cites W2102625211 @default.
• W2005698822 cites W2106399406 @default.
• W2005698822 cites W2106573383 @default.
• W2005698822 cites W2106952947 @default.
• W2005698822 cites W2107458343 @default.
• W2005698822 cites W2109795756 @default.
• W2005698822 cites W2111482500 @default.
• W2005698822 cites W2116120475 @default.
• W2005698822 cites W2122119235 @default.
• W2005698822 cites W2130681958 @default.
• W2005698822 cites W2137265165 @default.
• W2005698822 cites W2139099862 @default.
• W2005698822 cites W2139373697 @default.
• W2005698822 cites W2143869213 @default.
• W2005698822 cites W2150105676 @default.
• W2005698822 cites W2153236387 @default.
• W2005698822 cites W2154596823 @default.
• W2005698822 cites W2161358451 @default.
• W2005698822 cites W2331287401 @default.
• W2005698822 cites W2331642892 @default.
• W2005698822 cites W2334701948 @default.
• W2005698822 cites W4299648375 @default.
• W2005698822 doi "https://doi.org/10.1185/030079904x3104" @default.
• W2005698822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15537472" @default.
• W2005698822 hasPublicationYear "2004" @default.
• W2005698822 type Work @default.
• W2005698822 sameAs 2005698822 @default.
• W2005698822 citedByCount "12" @default.
• W2005698822 countsByYear W20056988222012 @default.
• W2005698822 countsByYear W20056988222014 @default.
• W2005698822 countsByYear W20056988222020 @default.
• W2005698822 crossrefType "journal-article" @default.
• W2005698822 hasAuthorship W2005698822A5001571542 @default.
• W2005698822 hasConcept C126322002 @default.
• W2005698822 hasConcept C177713679 @default.
• W2005698822 hasConcept C197934379 @default.
• W2005698822 hasConcept C2776042228 @default.
• W2005698822 hasConcept C2776136866 @default.
• W2005698822 hasConcept C2776719499 @default.
• W2005698822 hasConcept C2776804153 @default.
• W2005698822 hasConcept C2776999253 @default.
• W2005698822 hasConcept C2777288759 @default.
• W2005698822 hasConcept C2777450039 @default.
• W2005698822 hasConcept C2778375690 @default.
• W2005698822 hasConcept C2779028295 @default.
• W2005698822 hasConcept C2779871671 @default.
• W2005698822 hasConcept C2780261241 @default.
• W2005698822 hasConcept C2781212218 @default.
• W2005698822 hasConcept C42219234 @default.
• W2005698822 hasConcept C71924100 @default.
• W2005698822 hasConcept C98274493 @default.
• W2005698822 hasConceptScore W2005698822C126322002 @default.
• W2005698822 hasConceptScore W2005698822C177713679 @default.
• W2005698822 hasConceptScore W2005698822C197934379 @default.
• W2005698822 hasConceptScore W2005698822C2776042228 @default.
• W2005698822 hasConceptScore W2005698822C2776136866 @default.
• W2005698822 hasConceptScore W2005698822C2776719499 @default.
• W2005698822 hasConceptScore W2005698822C2776804153 @default.
• W2005698822 hasConceptScore W2005698822C2776999253 @default.
• W2005698822 hasConceptScore W2005698822C2777288759 @default.
• W2005698822 hasConceptScore W2005698822C2777450039 @default.
• W2005698822 hasConceptScore W2005698822C2778375690 @default.
• W2005698822 hasConceptScore W2005698822C2779028295 @default.
• W2005698822 hasConceptScore W2005698822C2779871671 @default.
• W2005698822 hasConceptScore W2005698822C2780261241 @default.
• W2005698822 hasConceptScore W2005698822C2781212218 @default.

• next